Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 3 of 115, showing 5 Applications out of 574 total, starting on record 11, ending on 15

# Protocol No Study Title Investigator(s) & Site(s)

11.

ECCT/25/12/01   Accetability testing Study
    Assessing the acceptability of enhanced multiple micronutrient supplements among pregnant women in Bungoma County       
Principal Investigator(s)
1. Zipporah Nekesa Bukania
Site(s) in Kenya
Tongaren Subcounty, Bungoma County
 
View

12.

ECCT/25/11/07   MK-8527 as HIV-1 PrEP
    Protocol Title: A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis   
Principal Investigator(s)
1. John Mark Ayallo
2. Kelvin Jerry Wandera
3. John Okanda
4. Joash Diemo
5. Tobias Odwar
6. Jacob Onyango
Site(s) in Kenya
1. Kenya Impact Research and Development Organization (K-IRDO) (Kisumu county)
2. Nyanza Reproductive Health Society (NRHS), UNIM Research and Training Center (URTC) (Kisumu county)
3. Partners for Health and Development in Africa – Sex workers Outreach Program (PHDA – SWOP) (Nairobi City county)
 
View

13.

ECCT/25/11/06   MK-8527-011 Study
    A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis   
Principal Investigator(s)
1. Dr Maricianah Onono
Site(s) in Kenya
1. Nyanza Reproductive Health Society (NRHS), UNIM Research and Training Centre (URTC) (Kisumu county)
2. Kenya Impact Research and Development Organization (K-IRDO) (Kisumu county)
3. Partners for Health and Development in Africa – Sex workers Outreach Program (PHDA – SWOP) Clinic- Nairobi, Kenya (Nairobi City county)
 
View

14.

ECCT/25/11/05   MK-8527-011 Study
    A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis   
Principal Investigator(s)
1. Dr. Joshua Kimani
Site(s) in Kenya
1. Nyanza Reproductive Health Society (NRHS), UNIM Research and Training Centre (URTC) (Kisumu county)
2. Partners for Health and Development in Africa – Sex workers Outreach Program (PHDA – SWOP) Clinic- Nairobi, Kenya (Nairobi City county)
3. Kenya Impact Research and Development Organization (K-IRDO) (Kisumu county)
 
View

15.

ECCT/25/11/04   Bifin02 and LGG®
    A Phase 3, randomized, double-blind, placebo-controlled trial to evaluate the effect of Bifidobacterium longum subsp. infantis DSM33361(Bifin02) administered together with Lacticaseibacillus rhamnosus GG DSM33156 (LGG®) versus placebo on weight gain in underweight infants   
Principal Investigator(s)
1. Charity Wambui Kanyoro
Site(s) in Kenya
1. Moi University Clinical Research (Uasin Gishu county)
2. Kenya Medical Research Institute (KEMRI) CRDR Off Raila Odinga, Nairobi Kenya (Nairobi City county)
3. Kenya Medical Research Institute (KEMRI) Mwtapa (Kilifi county)
 
View